Prollenium Medical Technologies, a manufacturer of medical devices and dermal fillers used in cosmetic and plastic surgery treatments worldwide, has opened a new facility, just north of Toronto, Canada. Its flagship product lines include Revanesse, Phiderma and RheoVital.
The company reports that the new facility is ISO 13485 registered as well as Health Canada and CE approved. It employs a fully automated process in a clean room environment with sterilization, packaging and quality control taking place in-house. The site also houses the company's marketing, sales and R&D teams.
"This new facility now offers a much more proactive opportunity for us to meet changes in the marketplace," says Chief Executive, Ario Khoshbin, "Allowing us to better innovate our products and introduce new product extension lines to the market."